ABBV-744 clinical trial phase 2 data Things To Know Before You Buy
These side effects were being notably milder as compared to an inhibitor of equally bromodomains. A detailed molecular analysis also unveiled that ABBV-744 preferentially inhibits the expression of Androgen Receptor (AR)-dependent genes. ― Stephen TaylorUbiquitin-relevant proteins that control the stability of essential Tremendous enhancer-medi